SCHEMBL7043536

SCHEMBL7043536

COc1ccc(-c2cccs2)n2nc(NC(=O)c3cccc(Cl)c3)nc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.48
THRB P10828 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
KDM4E B2RXH2 8/20 0.47
POLB P06746 2/20 0.47
TDP2 O95551 3/20 0.45
ALDH1A1 P00352 5/20 0.43
NPC1 O15118 3/20 0.43
HPGD P15428 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
PTGS2 P35354 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
GRM5 P41594 2/20 0.42
GCK P35557 1/20 0.41
LMNA P02545 2/20 0.41
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7147869 0.90 NPC1 (0.56) MAPTTHRBTDP1KDM4EALDH1A1
SCHEMBL7041685 0.90 GABRD (0.47) MAPTKDM4EPOLBALDH1A1NPC1
SCHEMBL7148818 0.89 KDM4E (0.42) MAPTTHRBKDM4EPOLBALDH1A1
SCHEMBL7042535 0.89 CYP1A2 (0.44) MAPTTHRBTDP1KDM4EPOLB
SCHEMBL7143995 0.85 ADORA1 (0.53) MAPTTDP1KDM4ETDP2ALDH1A1
SCHEMBL7146666 0.85 ALDH1A1 (0.53) MAPTTDP1KDM4EPOLBALDH1A1
SCHEMBL7042500 0.84 MAPT (0.46) MAPTTHRBTDP1KDM4EALDH1A1
SCHEMBL7151229 0.83 KMT2A (0.51) MAPTKDM4EPOLBALDH1A1NPC1
SCHEMBL7041864 0.83 HDAC6 (0.44) MAPTTHRBKDM4EPOLBALDH1A1
SCHEMBL7145678 0.80 MAPT (0.44) MAPTKDM4EPOLBALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1412352-A1 8-METHOXY-(1,2,4)TRIAZOLO(1,5-A)PYRIDINE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2004-04-28 EP claimed
WO-2003010167-A1 8-METHOXY-(1,2,4)TRIAZOLO(1,5-A)PYRIDINE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2003-02-06 WO claimed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US claimed
EP-1412352-A1 8-METHOXY-(1,2,4)TRIAZOLO(1,5-A)PYRIDINE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2004-04-28 EP disclosed
WO-2003010167-A1 8-METHOXY-(1,2,4)TRIAZOLO(1,5-A)PYRIDINE DERIVATIVES AND THEIR USE AS ADENOSINE RECEPTOR LIGANDS F. HOFFMANN-LA ROCHE AG (CH) 2003-02-06 WO disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed